Silverback Therapeutics shares owned by Octagon Capital Advisors
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Octagon Capital Advisors
from 13F filings
Historical chart of Octagon Capital Advisors investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Octagon Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $24M | 1.4M | 17.45 |
| 2025-03-31 | $7.9M | 625k | 12.58 |